Neoleukin Therapeutics, Inc. (NLTX) SEC filings

NLTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NLTX overview →

6 measured NLTX SEC filing events.

DateHeadlineEvent5-minTo close
Form 8-K Neurogene Inc. For: Dec 13SEC filing · Form 8-K——
Form 8-K Neoleukin Therapeutics, For: Dec 06SEC filing · Form 8-K—+1.99%
Form 8-K Neoleukin Therapeutics, For: Nov 30SEC filing · Form 8-K—-6.61%
Form 10-Q Neoleukin Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.00%+5.74%
Form EFFECT Neoleukin Therapeutics,SEC filing · Form EFFECT+0.00%+5.74%
Form S-4/A Neoleukin Therapeutics,SEC filing · Form S-4—-1.74%
Get an email when NLTX moves on news →
Keep exploring

More NLTX: earnings → · analyst actions → · NLTX overview →